无锡市第四人民医院，是位于中国江苏省无锡市滨湖区惠河路200号的一所历史上的医院，为三级甲等医院。 位于无锡市滨湖区惠河路200号。2004年12月18日，无锡市第四人民医院新病房大楼建成，总投资1.6亿元。2019年4月，无锡市第四人民医院与无锡市第三人民医院整合为江南大学附属医院。

During the past decade, Affiliated Hospital of Jiangnan University conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Affiliated Hospital of Jiangnan University" #1 sponsor was "Affiliated Hospital of Jiangnan University" with 7 trials, followed by "GeneScience Pharmaceuticals Co., Ltd." with 5 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Affiliated Hospital of Jiangnan University" #1 collaborator was "Children's Hospital of Fudan University" with 4 trials as a collaborator, "The First Hospital of Jilin University" with 4 trials as a collaborator, "Affiliated Hospital of Jiangnan University" with 3 trials as a collaborator, "Shanghai Children's Hospital" with 3 trials as a collaborator and "The Children's Hospital of Zhejiang University School of Medicine" with 3 trials as a collaborator. Other collaborators include 15 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Affiliated Hospital of Jiangnan University" are "Carcinoma, Non-Small-Cell Lung" (2 trials), "Colorectal Cancer" (2 trials), "Dwarfism" (2 trials), "Acute Myocardial Infarction" (1 trials) and "Advanced Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Affiliated Hospital of Jiangnan University" in a lesser frequency.

Most popular intervention types in "Affiliated Hospital of Jiangnan University" are "Drug" (36 trials), "Biological" (6 trials), "Diagnostic Test" (1 trials), "Genetic" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Carboplatin" (3 trials), "PEG-somatropin" (3 trials), "Amivantamab" (2 trials) and "Capecitabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Affiliated Hospital of Jiangnan University" are 37 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Affiliated Hospital of Jiangnan University". 3 are not yet recruiting, 19 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Affiliated Hospital of Jiangnan University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Affiliated Hospital of Jiangnan University, 6 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".